Detection and quantification of overactive bladder activity in patients: Can we make it better and automatic?

Overactive Bladder

Patient-targeted websites on overactive bladder: What are our patients reading?

Neurourol Urodyn.

Clancy AA, Hickling D, Didomizio L, Sanaee M, Shehata F, Zee R, Khalil H

doi: 10.1002/nau.23359.

Overactive Bladder

International Phase III, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR

J Urol.

Staskin D, Frankel J, Varano S, Shortino D, Jankowich R, Mudd PN Jr

doi: 10.1097/JU.0000000000000807.

Overactive Bladder

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Health Qual Life Outcomes.

Herschorn S, Staskin D, Tu LM, Fialkov J, Walsh T, Gooch K, Schermer CR

doi: 10.1186/s12955-018-0892-0.

Overactive Bladder

Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

Neurourol Urodyn.

Mueller ER, van Maanen R, Chapple C, Abrams P, Herschorn S, Robinson D, Stoelzel M, Yoon SJ, Al-Shukri S, Rechberger T, Gratzke C

doi: 10.1002/nau.23919.

Overactive Bladder

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

Patient.

Herdman M, Nazir J, Hakimi Z, Siddiqui E, Huang M, Pavesi M, MacDiarmid S, Drake MJ, Devlin N

doi: 10.1007/s40271-017-0262-8.

Overactive BladderUrinary Incontinence

Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?

Int Urogynecol J.

Goldman HB, Oelke M, Kaplan SA, Kitta T, Russell D, Carlsson M, Arumi D, Mangan E, Ntanios F

doi: 10.1007/s00192-018-3640-4.

Overactive BladderMenopause

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Eur J Obstet Gynecol Reprod Biol.

Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A

doi: 10.1016/j.ejogrb.2018.01.002.

Lower Urinary Tract SymptomsOveractive BladderUrinary IncontinenceUrinary Tract Infections (UTI)

Are the Electronic and Paper Questionnaires Equivalent in Assessing Patients with Overactive Bladder?

J Urol.

Palmer C, Farhan B, Nguyen N, Zhang L, Do R, Nguyen DV, Ghoniem G

doi: 10.1016/j.juro.2018.03.117.

Overactive Bladder

Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome

Lupus.

Pereira E Silva R, Romão VC, Neves M, Garcia R, Oliveira S, Brites J, Ramos FO, Canhão H, Palma Dos Reis J, Pereira da Silva JA, Lopes T

doi: 10.1177/0961203318811605.

Related content

Patient-targeted websites on overactive bladder: What are our patients reading?

International Phase III, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Are the Electronic and Paper Questionnaires Equivalent in Assessing Patients with Overactive Bladder?

Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome